Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track BMRA with free AI briefings, catalyst countdowns, and dilution alerts.

BMRA · Biomerica, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$1.3M Cash, May 2026

5mo Cash Runway (est.)

+60% Share Count, 1 Year

Follow BMRA by email Get an email when BMRA pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about BMRA, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

BMRA reported $1.3M in cash and short-term investments (as of May 31, 2026) and used about $855,250/quarter in operations, an estimated runway of 4.6 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 75 · High

Cash runway 5 months +40
ATM program on file since May 2024 +15
Shelf registration (S-3, Sep 2026) +10
Share count +60% in a year +20
Raised after last reported balance sheet (Aug 2026) -10

Recent financing filings on SEC EDGAR:

Sep 24, 2026 · Shelf registration · S-3
Aug 26, 2026 · Private placement (8-K Item 3.02) · 8-K
May 10, 2024 · ATM program, up to $6M · 424B5
Sep 28, 2023 · Shelf registration, up to $20M · S-3

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when BMRA files for a raise →

Get the full BMRA picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for BMRA and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z